Search - Leibniz Institute for Prevention Research and Epidemiology

411. [BIPS Project] Cross-departmental Center A: Research Data Infrastructure

URL: /en/research/projects/detail-view.html?projID=1049&cHash=a7588da6ccc395c3d3f81ba0c490fec4
Date: 01-01-23

High quality research data are essential for epidemiological research. Generally, it is not possible to fully exploit the potential of the research data generated in individual research projects…

412. [BIPS Project] Post-authorisation safety study of tralokinumab use in pregnancy

URL: /en/research/projects/detail-view.html?projID=1040&cHash=61d281ea60f3f02b443b69dfb3b9577a
Date: 01-01-23

Tralokinumab is a biological agent developed for the treatment of moderate to severe atopic dermatitis (AD) and is administered by subcutaneous injection. Tralokinumab is a fully human immunoglobulin…

413. [BIPS Project] Evaluation of "Bewegung in der Grundschule"

URL: /en/research/projects/detail-view.html?projID=1042&cHash=f92c1c013512e1702bd0e7d9d994620a
Date: 01-01-23

EVA BiG evaluates the program for the promotion of physical activity "Bewegung in der Grundschule" (Physical Activity in Elementary School), which is carried out by the Kreissportbund Bremen-Nord in…

414. Monitoring of Drug Utilization and Safety

URL: /en/the-institute/departments/clinical-epidemiology/monitoring-of-drug-utilization-and-safety.html
Date: 10-01-23

More units Translational Cancer Epidemiology Pharmacoepidemiology in Vulnerable Groups Research infrastructures GePaRD Bremen Cancer Registry Bremen Mortality Index Jonas Reinold …

415. Selected publications in January

URL: /en/media/news/single-view/ausgewaehlte-publikationen-im-januar.html
Date: 12-01-23

How harmful is it to your health to live on a major road? Are info-mails from research institutes to stakeholders actually read? And: How must health policy be made so that plans for a healthier…

416. Pharmacoepidemiology in Vulnerable Groups

URL: /en/the-institute/departments/clinical-epidemiology/pharmacoepidemiology-in-vulnerable-groups.html
Date: 17-01-23

Research Infrastructures GePaRD Bremen Cancer Registry Bremen Mortality Index Ulrike Haug Temp. Head Contact: Prof. Dr. Ulrike Haug Tel: +49 (0)421 218-56862 Fax: +49 (0)421…

417. Achievements of our work

URL: /en/methodological-competence-platform/achievements-of-our-work.html
Date: 23-01-23

Achievements of our work Roadmap to harmonisation An inventory of current surveillance systems for diet, physical activity and sedentary behaviour was developed to…

418. Hajo Zeeb appointed deputy chairman of the Radiation Protection Commission

URL: /en/media/press/single-view/hajo-zeeb-zum-stellvertretenden-vorsitzenden-der-strahlenschutzkommission-berufen.html
Date: 26-01-23

Prof. Dr. Hajo Zeeb has been a member of the Radiation Protection Commission (SSK) since 2021. He heads the Department of Prevention and Evaluation at the Leibniz Institute for Prevention Research…

419. [BIPS Project] Drug utilization study to evaluate the effectiveness of additional risk minimization measures for upadacitinib in the treatment of atopic dermatitis

URL: /en/research/projects/detail-view.html?projID=1058&cHash=7c786a506c59206d88343acad19a145c
Date: 15-02-23

Upadacitinib (Rinvoq®) is a so-called Januskinase (JAK)-inhibitor which is approved for the treatment of chronic rheumatic diseases such as ulcerative colitis, rheumatic arthritis and atopic…

420. About the Institute

URL: /en/the-institute/about-the-institute.html
Date: 16-02-23

Health Research in the Service of the People The Leibniz Institute for Prevention Research and Epidemiology - BIPS develops effective strategies for the prevention of chronic, non-communicable…